4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000009
Chief Medical Officer sold 10,859 shares at $1.85 ($20,047)
- Chief Medical Officer acquired 66,800 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Siemers Eric Chief Medical Officer | 2025-01-03 | Sale 10b5-1 | −10,859 | $1.85 | $20,047 | 106,717 | D |
| Siemers Eric Chief Medical Officer | 2025-01-06 | Grant or award 10b5-1 | +66,800 | 173,517 | D | ||
| Derivatives | |||||||
| Siemers Eric Chief Medical Officer | 2025-01-06 | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,300 | 100,300 | D | ||
| Open-market sales · 10,859 sh · avg $1.85 · $20,047 | |||||||
Loading xslF345X05/wk-form4_1736297327.xml…